This Biotech Stock Should Be On Readers’ Watch List


Oncology Pharma, Inc is a San Francisco-based biotech company that has been going up a lot this year.

Its CEO, Dr. Vijay Mahant received his MS., Ph.D.  and first post-doctorate from LUT (UK).

He has been issued 30 patents so far with 10 more currently pending and has authored publications in journals and science books throughout the world.

He has developed several products with revenues and continues his role of advising Batu Biologics, CHIPSA Hospital, Trutino Biosciences, TulyNode and Immunicom.

Readers should have Oncology Pharma, Inc on their watch list as things could get interesting from here.